Cargando…

Old Age is an Independent Risk Factor for Pneumonia Development in Patients with SARS-CoV-2 Omicron Variant Infection and a History of Inactivated Vaccine Injection

OBJECTIVE: Analyzing the risk factors for pneumonia development in breakthrough cases with a history of inactivated vaccine injection is important. The present study aimed to investigate the risk factors for pneumonia development during Omicron variant infection. DESIGN AND METHODS: The clinical dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Xuecheng, Huang, Zeyu, Zhang, Xiujun, Si, Guocan, Lu, Huifen, Zhang, Wei, Xue, Yuan, Xie, Weibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512030/ https://www.ncbi.nlm.nih.gov/pubmed/36172623 http://dx.doi.org/10.2147/IDR.S380005

Ejemplares similares

SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose
por: Zhang, Xiujun, et al.
Publicado: (2022)

Omicron variant: a booster depending on infection histories
por: Wang, Jiayu, et al.
Publicado: (2023)

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
por: Ong, Chon Phin, et al.
Publicado: (2023)

Wavelength dependence of ultraviolet light inactivation for SARS-CoV-2 omicron variants
por: Fujimoto, Nahoko, et al.
Publicado: (2023)

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
por: Lu, Changrui, et al.
Publicado: (2023)

Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients
por: Zhang, Lei, et al.
Publicado: (2023)

Protective Effect of Inactivated COVID-19 Vaccines against Progression of SARS-CoV-2 Omicron and Delta Variant Infections to Pneumonia in Beijing, China, in 2022
por: Li, Juan, et al.
Publicado: (2022)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

Comparative analysis of transmission and vaccine effectiveness in Omicron and Delta variant outbreaks in China
por: Li, Kangguo, et al.
Publicado: (2023)

Omicron variant Spike-specific antibody binding and Fc activity is preserved in recipients of mRNA or inactivated COVID-19 vaccines
por: Bartsch, Yannic C., et al.
Publicado: (2022)

The emergence of the Omicron variant
por: Toovey, Oliver T.R., et al.
Publicado: (2022)

Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection
por: Simayi, Aidibai, et al.
Publicado: (2023)

Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
por: Gao, Bo, et al.
Publicado: (2023)

Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, China
por: Guo, Jun, et al.
Publicado: (2023)

Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice
por: Liu, Shufeng, et al.
Publicado: (2022)

Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities
por: Alam, Mohammad Shah
Publicado: (2023)

The Quantification of Spike Proteins in the Inactivated SARS-CoV-2 Vaccines of the Prototype, Delta, and Omicron Variants by LC–MS
por: Xu, Kangwei, et al.
Publicado: (2023)

Omicron variant of SARS-COV-2 in Shanghai: Clinical features and inactivated vaccine efficacy in 13,120 elderly patients
por: Li, Jingwen, et al.
Publicado: (2023)

Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China
por: Xu, Hongqin, et al.
Publicado: (2023)

Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China
por: Wang, Kai, et al.
Publicado: (2023)

Can the Omicron variant of COVID‐19 cause pneumonia in young patients without risk factors?
por: Ito, Noriaki, et al.
Publicado: (2022)

Heterogeneity of the Omicron variant in Senegal
por: Diédhiou, Cyrille Kouligueul, et al.
Publicado: (2022)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines
por: Zhao, Xin, et al.
Publicado: (2022)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
por: Lavezzo, Enrico, et al.
Publicado: (2022)

Fatal multisystem inflammatory syndrome in a 78-year-old adult after severe COVID-19 pneumonia during 2022 Omicron variant epidemic in Shanghai, China
por: Su, Yang, et al.
Publicado: (2023)

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
por: Wang, Xun, et al.
Publicado: (2022)

Inactivated COVID-19 vaccine booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2
por: Wu, Jun, et al.
Publicado: (2023)

Impacts of delta and omicron variants on inactivated SARS‐CoV‐2 vaccine‐induced T cell responses in patients with autoimmune diseases and healthy controls
por: Wang, Shuyi, et al.
Publicado: (2023)

Immunological and metabolic characteristics of the Omicron variants infection
por: Geng, Jiejie, et al.
Publicado: (2023)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages
por: Guo, Li, et al.
Publicado: (2023)

Inactivation of Lactobacillus Bacteriophages by Dual Chemical Treatments
por: XU, MING, et al.
Publicado: (2023)

Aktuelle Informationen zur Omicron-Variante
por: Hasibeder, Walter
Publicado: (2022)

Omicron: a mysterious variant of concern
por: Gowrisankar, A., et al.
Publicado: (2022)

The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis
por: Liu, Kai, et al.
Publicado: (2022)

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
por: Zuo, Fanglei, et al.
Publicado: (2022)

Genomic Insights Into the Evolution and Demographic History of the SARS-CoV-2 Omicron Variant: Population Genomics Approach
por: Garg, Kritika M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_89qnv46pue2r92ed62hdnhudgq